Covered recipient · General Payments record
JASRUP KAUR
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,978.44
- Reported across 483 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $627.84 | 46 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $219.54 | 15 |
| ABBVIE INC. | $214.59 | 18 |
| PFIZER INC. | $43.73 | 3 |
| Currax Pharmaceuticals LLC | $43.06 | 3 |
| GlaxoSmithKline, LLC. | $30.98 | 2 |
| Amgen Inc. | $26.88 | 2 |
| Astellas Pharma US Inc | $20.09 | 1 |
| Acerta Pharma LLC | $15.87 | 1 |
| Exact Sciences Corporation | $13.10 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (46)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.83 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042418 | CMS |
| ABBVIE INC. | $13.98 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042420 | CMS |
| ABBVIE INC. | $13.58 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042422 | CMS |
| ABBVIE INC. | $9.99 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042424 | CMS |
| ABBVIE INC. | $13.26 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042426 | CMS |
| ABBVIE INC. | $9.06 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042428 | CMS |
| ABBVIE INC. | $10.16 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042430 | CMS |
| ABBVIE INC. | $10.47 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042432 | CMS |
| ABBVIE INC. | $16.28 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042434 | CMS |
| ABBVIE INC. | $10.10 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042436 | CMS |
| ABBVIE INC. | $13.58 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042438 | CMS |
| ABBVIE INC. | $14.35 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042440 | CMS |
| ABBVIE INC. | $13.98 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042442 | CMS |
| ABBVIE INC. | $14.38 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042444 | CMS |
| ABBVIE INC. | $9.42 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042446 | CMS |
| ABBVIE INC. | $7.94 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042448 | CMS |
| ABBVIE INC. | $13.94 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042450 | CMS |
| ABBVIE INC. | $7.29 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104042452 | CMS |
| Amgen Inc. | $13.12 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111616069 | CMS |
| Amgen Inc. | $13.76 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111616067 | CMS |
| Astellas Pharma US Inc | $20.09 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139326948 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.87 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104589994 | CMS |
| Currax Pharmaceuticals LLC | $14.16 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511544 | CMS |
| Currax Pharmaceuticals LLC | $13.10 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511546 | CMS |
| Currax Pharmaceuticals LLC | $15.80 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089511548 | CMS |
| Exact Sciences Corporation | $13.10 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114728918 | CMS |
| GlaxoSmithKline, LLC. | $15.14 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115742876 | CMS |
| GlaxoSmithKline, LLC. | $15.84 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115912778 | CMS |
| Novo Nordisk Inc | $15.17 | 01/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097515865 | CMS |
| Novo Nordisk Inc | $10.47 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097478044 | CMS |
| Novo Nordisk Inc | $16.48 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096599579 | CMS |
| Novo Nordisk Inc | $14.27 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096902501 | CMS |
| Novo Nordisk Inc | $13.58 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096915224 | CMS |
| Novo Nordisk Inc | $17.56 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097454954 | CMS |
| Novo Nordisk Inc | $17.82 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096941530 | CMS |
| Novo Nordisk Inc | $16.25 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096850924 | CMS |
| Novo Nordisk Inc | $12.18 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097337736 | CMS |
| Novo Nordisk Inc | $11.72 | 07/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096955079 | CMS |
| Novo Nordisk Inc | $15.22 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097316796 | CMS |
| Novo Nordisk Inc | $15.99 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097552125 | CMS |
| Novo Nordisk Inc | $18.96 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097837424 | CMS |
| Novo Nordisk Inc | $11.66 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097155926 | CMS |
| Novo Nordisk Inc | $12.21 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097834902 | CMS |
| PFIZER INC. | $13.97 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131154004 | CMS |
| PFIZER INC. | $13.56 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132038726 | CMS |
| PFIZER INC. | $16.20 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130883770 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.